Serum molecular signatures of weight change during early breast cancer chemotherapy

Clinical Cancer Research

Volumn 15, Issue 21, 2009, Pages 6716-6723

  Keun, Hector C ^a   Sidhu, Jasmin ^a   Pchejetski, Dmitry ^b   Lewis, Jacqueline S ^b   Marconell, Helena ^b   Patterson, Michael ^a   Bloom, Steven R ^a   Amber, Vian ^a   Coombes, R Charles ^b   Stebbing, Justin ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INTERLEUKIN 6; LACTIC ACID; PEPTIDE YY; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT CHEMOTHERAPY; APPETITE; ARTICLE; BODY FAT; BODY MASS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; IMMUNOREACTIVITY; LACTATE BLOOD LEVEL; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOIMMUNOASSAY; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INTERLEUKIN-6; LACTATES; PEPTIDE YY; POSTMENOPAUSE; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 70350716444     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1452     Document Type: Article

References (49)

1. Rock CL, Flatt SW, Newman V, et al. Factors associated with weight gain in women after diagnosis of breast cancer. Women's healthy eating and living study group. J AmDiet Assoc 1999;99: 1212-1221
2. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001;19: 2381-2389
3. Dixon JK, Moritz DA, Baker FL. Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum 1978;5:5-7.
4. Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer 1978;41:1590-1594 (Pubitemid 8333319)
5. Huntington MO. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 1985;56:472-474 (Pubitemid 15035571)
6. Goodwin PJ. Weight gain in early-stage breast cancer: where do we go from here? J Clin Oncol 2001;19:2367-2369
7. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-1143 (Pubitemid 34141858)
8. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-1378 (Pubitemid 46260024)
9. Caan BJ, Emond JA, Natarajan L, et al. Postdiagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 2006;99:47-57.
10. Litton JK, Gonzalez-Angulo AM, Warneke CL, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 2008;26:4072-4077
11. Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebocontrolled trial. J Clin Endocrinol Metab 2004; 89:2832-2836
12. Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98:1767-1776
13. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a meta-analysis. Int J Cancer 2008;124:698-712.
14. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007; 25:2345-2351
15. Keun HC, Athersuch TJ. Application of metabonomics in drug development. Pharmacogenomics 2007;8:731-741
16. Boneva-Asiova Z, Boyanov MA. Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X-ray absorptiometry in non-obese and obese individuals. Diabetes Obes Metab 2008;10:1012-1018
17. Patterson M, Murphy KG, le Roux CW, Ghatei MA, Bloom SR. Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 2005;90:2205-2211 (Pubitemid 40586263)
18. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2:1300-1304
19. Gardiner J, Bloom S. Ghrelin gets its GOAT. Cell Metab 2008;7:193-194
20. Parkinson JR, Dhillo WS, Small CJ, et al. PYY3- 36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones. Am J Physiol Endocrinol Metab 2008;294:E698-708.
21. Parkinson JR, Chaudhri OB, Kuo YT, et al. Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese- enhanced magnetic resonance imaging (MEMRI). Neuroimage 2008;44:1022-1031
22. Field BC, Wren AM, Cooke D, Bloom SR. Gut hormones as potential new targets for appetite regulation and the treatment of obesity. Drugs 2008;68:147-163
23. Russell SH, Small CJ, Stanley SA, Franks S, Ghatei MA, Bloom SR. The in vitro role of tumour necrosis factor-α and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol 2001;13:296-301. (Pubitemid 32170995)
24. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986;320:584-588
25. Ravasco P, Monteiro-Grillo I, Camilo M. How relevant are cytokines in colorectal cancer wasting? Cancer J 2007;13:392-398
26. Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 2008;10:1477-1483
27. Dang CV. The interplay between MYC and HIF in the Warburg effect. Ernst Schering Found Symp Proc 2007:35-53.
28. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008;134:703-707
29. Hill JO, Thacker S, Newby D, Sykes MN, Digirolamo M. Influence of food restriction coupled with weight cycling on carcass energy restoration during ad-libitum refeeding. Int J Obes 1988;12:547-555
30. DiGirolamo M, Newby FD, Lovejoy J. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 1992;6:2405-2412
31. Crawford SO, Ambrose MS, Hoogeveen RC, Brancati FL, Ballantyne CM, Young JH. Association of lactate with blood pressure before and after rapid weight loss. Am J Hypertens 2008;21: 1337-1342
32. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-628
33. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51: 2944-2950
34. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100: 8466-8471 (Pubitemid 36842568)
35. Domenech M, Lopez-Soriano FJ, Marzabal M, Argiles JM. Amino acid metabolism enzyme activities in the obese Zucker rat. Cell Mol Biol (Noisy-le-grand) 1993;39:405-414
36. Saxena NK, Taliaferro-Smith L, Knight BB, et al. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 2008;68: 9712-9722
37. Jin Q, Esteva FJ. Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia 2008;13:485-498
38. Lann D, Leroith D. The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia 2008; 13:371-379
39. Sen A, Jen KL, Djuric Z. Baseline leptin levels predict change in leptin levels during weight loss in obese breast cancer survivors. Breast J 2007; 13:180-186 (Pubitemid 46280607)
40. Goldstone AP, Mercer JG, Gunn I, et al. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 1997;415:134-138 (Pubitemid 27430055)
41. Small CJ, Stanley SA, Bloom SR. Appetite control and reproduction: leptin and beyond. Semin Reprod Med 2002;20:389-398
42. Lopez-Rios F, Sanchez-Arago M, Garcia- Garcia E, et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 2007;67: 9013-9017 (Pubitemid 47535883)
43. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13:472-482
44. Schwickert G, Walenta S, Sundfor K, Rofstad EK,Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55:4757-4759
45. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60: 916-921
46. Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 2008;118: 3835-3837
47. Sonveaux P, Vegran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118:3930-3942
48. Keun HC. Biomarker discovery for drug development and translational medicine using metabonomics. Ernst Schering Found Symp Proc 2007:79-98.
49. Clayton TA, Lindon JC, Cloarec O, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006;440: 1073-1077